IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mirna Therapeutics Inc

CUSIP: 60470J103 | 26 institutional holders

Quarters

Q3 2022Q1 2022Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2022

Endurance Wealth Management, Inc.4,900
0.0% of portfolio›$5
StyleTurnoverLocationFiled
Endurance Wealth Management, Inc.
4,900$50.0%N/AN/AProvidence, RI2022-10-21